Table 4.
Assay 1 | Assay 2 | Time | Correlation* |
---|---|---|---|
IgG against ZEBOV GP (concentration) | NAb against ZEBOV GP | 0 | 0.08 |
IgG against ZEBOV GP (concentration) | NAb against ZEBOV GP | 28 | 0.44 |
IgG against ZEBOV GP (concentration) | IgG against whole virion | 0 | 0.30 |
IgG against ZEBOV GP (concentration) | IgG against whole virion | 28 | 0.52 |
IgG against ZEBOV GP (concentration) | NAb against whole virion | 0 | 0.35 |
IgG against ZEBOV GP (concentration) | NAb against whole virion | 28 | 0.40 |
NAb against ZEBOV GP | IgG against whole virion | 0 | N/A |
NAb against ZEBOV GP | IgG against whole virion | 28 | 0.16 |
NAb against ZEBOV GP | NAb against whole virion | 0 | N/A |
NAb against ZEBOV GP | NAb against whole virion | 28 | 0.34 |
IgG against whole virion | NAb against whole virion | 0 | −0.02 |
IgG against whole virion | NAb against whole virion | 28 | 0.48 |
Spearman rank correlation coefficient estimated for those whose antibody response was available for per-protocol analysis by both assays.